Advanced Oncotherapy draws third tranche of Bracknor financing
Advanced Oncotherapy has drawn net proceeds of £1.235m in the third tranche of its Bracknor financing.
Advanced Oncotherapy
1.92p
17:30 03/05/24
0.00%
0.00p
FTSE AIM All-Share
728.67
15:45 15/11/24
n/a
n/a
Health Care Equipment & Services
10,430.75
15:44 15/11/24
0.23%
23.76
The company is a developer of next-generation proton therapy systems for cancer treatment.
In previous statements, Advanced Oncotherapy said proceeds from the Bracknor financing would continue to be allocated to its projects and for general working capital purposes.
At 14:18 BST, shares in Advanced Oncotherapy were down 4.49% at 21.25p each.